These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 20183574)
41. RNAi depletion of deoxycytidine and deoxyguanosine kinase in human leukemic CEM cells. Fyrberg A; Albertioni F; Lotfi K Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):712-9. PubMed ID: 18600530 [TBL] [Abstract][Full Text] [Related]
42. In vitro assessment of nucleoside analogs in multiple myeloma. Krett NL; Ayres M; Nabhan C; Ma C; Nowak B; Nawrocki S; Rosen ST; Gandhi V Cancer Chemother Pharmacol; 2004 Aug; 54(2):113-21. PubMed ID: 15133625 [TBL] [Abstract][Full Text] [Related]
43. Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage. Achanta G; Pelicano H; Feng L; Plunkett W; Huang P Cancer Res; 2001 Dec; 61(24):8723-9. PubMed ID: 11751391 [TBL] [Abstract][Full Text] [Related]
44. Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenografts. Bergman AM; Kuiper CM; Noordhuis P; Smid K; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Fodstad O; Breistøl K; Peters GJ Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1329-33. PubMed ID: 15571253 [TBL] [Abstract][Full Text] [Related]
45. An in vitro study of the inhibitory activity of gemcitabine and platinum agents in human endometrial carcinoma cell lines. Smith JA; Brown J; Martin MC; Ramondetta LM; Wolf JK Gynecol Oncol; 2004 Jan; 92(1):314-9. PubMed ID: 14751176 [TBL] [Abstract][Full Text] [Related]
46. Human cytosolic 5'-nucleotidase I: characterization and role in nucleoside analog resistance. Hunsucker SA; Spychala J; Mitchell BS J Biol Chem; 2001 Mar; 276(13):10498-504. PubMed ID: 11133996 [TBL] [Abstract][Full Text] [Related]
47. Interaction of 2',2'-difluorodeoxycytidine (gemcitabine) and formycin B with the Na+-dependent and -independent nucleoside transporters of Ehrlich ascites tumor cells. Burke T; Lee S; Ferguson PJ; Hammond JR J Pharmacol Exp Ther; 1998 Sep; 286(3):1333-40. PubMed ID: 9732397 [TBL] [Abstract][Full Text] [Related]
48. Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions. Andersson R; Aho U; Nilsson BI; Peters GJ; Pastor-Anglada M; Rasch W; Sandvold ML Scand J Gastroenterol; 2009; 44(7):782-6. PubMed ID: 19214867 [TBL] [Abstract][Full Text] [Related]
49. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug. Guillermet-Guibert J; Davenne L; Pchejetski D; Saint-Laurent N; Brizuela L; Guilbeau-Frugier C; Delisle MB; Cuvillier O; Susini C; Bousquet C Mol Cancer Ther; 2009 Apr; 8(4):809-20. PubMed ID: 19372554 [TBL] [Abstract][Full Text] [Related]
50. Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines. Bergman AM; Munch-Petersen B; Jensen PB; Sehested M; Veerman G; Voorn DA; Smid K; Pinedo HM; Peters GJ Biochem Pharmacol; 2001 Jun; 61(11):1401-8. PubMed ID: 11331076 [TBL] [Abstract][Full Text] [Related]
52. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE Cancer Res; 2004 Jun; 64(11):3987-93. PubMed ID: 15173012 [TBL] [Abstract][Full Text] [Related]
53. Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cells. Gandhi V; Mineishi S; Huang P; Yang Y; Chubb S; Chapman AJ; Nowak BJ; Hertel LW; Plunkett W Semin Oncol; 1995 Aug; 22(4 Suppl 11):61-7. PubMed ID: 7481847 [TBL] [Abstract][Full Text] [Related]
54. Induction of resistance to 2',2'-difluorodeoxycytidine in the human ovarian cancer cell line A2780. Ruiz van Haperen VW; Veerman G; Eriksson S; Stegmann AP; Peters GJ Semin Oncol; 1995 Aug; 22(4 Suppl 11):35-41. PubMed ID: 7481843 [TBL] [Abstract][Full Text] [Related]
55. Activation of p38 mitogen-activated protein kinase is necessary for gemcitabine-induced cytotoxicity in human pancreatic cancer cells. Koizumi K; Tanno S; Nakano Y; Habiro A; Izawa T; Mizukami Y; Okumura T; Kohgo Y Anticancer Res; 2005; 25(5):3347-53. PubMed ID: 16101149 [TBL] [Abstract][Full Text] [Related]
56. Probing the human kinome for kinases involved in pancreatic cancer cell survival and gemcitabine resistance. Giroux V; Iovanna J; Dagorn JC FASEB J; 2006 Oct; 20(12):1982-91. PubMed ID: 17012250 [TBL] [Abstract][Full Text] [Related]
57. cRGD grafted siRNA nano-constructs for chemosensitization of gemcitabine hydrochloride in lung cancer treatment. Khatri N; Rathi M; Baradia D; Misra A Pharm Res; 2015 Mar; 32(3):806-18. PubMed ID: 24792823 [TBL] [Abstract][Full Text] [Related]
58. Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells. Bocci G; Fioravanti A; Orlandi P; Bernardini N; Collecchi P; Del Tacca M; Danesi R Br J Cancer; 2005 Aug; 93(3):319-30. PubMed ID: 16052215 [TBL] [Abstract][Full Text] [Related]
59. Interferon-gamma down-regulates heat shock protein 27 of pancreatic cancer cells and helps in the cytotoxic effect of gemcitabine. Mori-Iwamoto S; Taba K; Kuramitsu Y; Ryozawa S; Tanaka T; Maehara S; Maehara Y; Okita K; Nakamura K; Sakaida I Pancreas; 2009 Mar; 38(2):224-6. PubMed ID: 19238023 [No Abstract] [Full Text] [Related]
60. Ribonucleotide reductase M1 (RRM1) 2464G>A polymorphism shows an association with gemcitabine chemosensitivity in cancer cell lines. Kwon WS; Rha SY; Choi YH; Lee JO; Park KH; Jung JJ; Kim TS; Jeung HC; Chung HC Pharmacogenet Genomics; 2006 Jun; 16(6):429-38. PubMed ID: 16708051 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]